EA
46
2
SLB
35
3
GS
59
-3
APH
59
-5
LEN
48
2
NEE
59
2
KLAC
50
-3
APA
34
2
AMG
72
-2
AVGO
31
-7
MDLZ
42
-2
NRG
60
-5
JPM
53
-2
NDAQ
57
-5
AES
41
-6
KMX
46
5
CSCO
53
-7
LOW
49
3
HOG
39
3
ACN
31
-5
EA
46
2
SLB
35
3
GS
59
-3
APH
59
-5
LEN
48
2
NEE
59
2
KLAC
50
-3
APA
34
2
AMG
72
-2
AVGO
31
-7
MDLZ
42
-2
NRG
60
-5
JPM
53
-2
NDAQ
57
-5
AES
41
-6
KMX
46
5
CSCO
53
-7
LOW
49
3
HOG
39
3
ACN
31
-5
Financhill
Back

Microsoft Vs. Akero Therapeutics Sector Stock Comparison

Buy
54

MSFT
Microsoft

Last Price:
$525.50
Seasonality Move:
5.8%
Buy
57

AKRO
Akero Therapeutics

Last Price:
$51.95
Seasonality Move:
33.63%
Buy
54
Microsoft (MSFT) is a Buy

Is Microsoft a Buy, Sell or Hold?

  • The current Microsoft [MSFT] share price is $527.75. The Score for MSFT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • MSFT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $49.56. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MSFT Stock Price Chart

What is Microsoft's stock price today?

  • The Microsoft share price today is $527.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSFT is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $49.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

MSFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 138.79 Buy
Relative Strength Index (14 RSI): 65.57 Buy
Chaikin Money Flow: -17227732 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (497.8 - 520.28) Buy
Bollinger Bands (100): (394.41 - 499.17) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.88 Sell
Relative Strength Index (14 RSI): 45.72 Sell
Chaikin Money Flow: 729251 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.18 - 52.6) Sell
Bollinger Bands (100): (40.51 - 52.73) Buy

MSFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 521.63 Buy
20-day SMA: 512.48 Buy
50-day SMA: 491.68 Buy
200-day SMA: 433.96 Buy
8-day EMA: 410.25 Buy
20-day EMA: 237.26 Buy
50-day EMA: 112.01 Buy
200-day EMA: 30.55 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.8 Buy
20-day SMA: 50.76 Sell
50-day SMA: 51.83 Sell
200-day SMA: 41.11 Buy
8-day EMA: 49.2 Buy
20-day EMA: 50.28 Sell
50-day EMA: 50.03 Sell
200-day EMA: 42.48 Buy

Microsoft Earnings Growth & MSFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.44 per share, an increase this year of $1.59 per share, and an increase next year of $2.09 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.58 per share.

Microsoft Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):